Evidence map›Paper›PMID 24759129›Full record

ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Neurodevelopment, GABA system dysfunction, and schizophrenia.

Martin J Schmidt, Karoly Mirnics

Abstract readReview
In one paragraph

Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Dystrophinopathy with aPCN reports : psychiatry and clinical neurosciences · 2026
    Article
  9. Isolation and genetic analysis of anBiochemistry and biophysics reports · 2026
    Article
  10. Article
  11. Spatially resolved translational dysregulation inbioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Proteostasis regulation of GABABiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
    Review
  17. Article
  18. Review
  19. Epigenetic Control in Schizophrenia.Sub-cellular biochemistry · 2025
    Review
  20. Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Martin J SchmidtDepartment of Psychiatry, Vanderbilt University, Nashville, TN, USA.
Karoly Mirnics1] Department of Psychiatry, Vanderbilt University, Nashville, TN, USA [2] Vanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, TN, USA [3] Department of Psychiatry, University of Szeged, Szeged, Hungary.

Funding

THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
Neocortical Transcriptome Changes in SchizophreniaR01MH067234 · NIMH · VANDERBILT UNIVERSITY · PI MIRNICS, KAROLY · 2003 to 2021
$4.7M
Neuroimmune Changes in SchizophreniaR01MH079299 · NIMH · VANDERBILT UNIVERSITY · PI MIRNICS, KAROLY · 2007 to 2011
$1.7M
Epigenome Mapping in Cortical InterneuronsR01MH093332 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI AKBARIAN, SCHAHRAM · 2011 to 2015
$1.7M
NICHD NIH HHS P30 HD015052NIMH NIH HHS R01 MH067234NIMH NIH HHS R01 MH079299NIMH NIH HHS R01 MH093332
6 · The paper itself

Abstract

The origins of schizophrenia have eluded clinicians and researchers since Kraepelin and Bleuler began documenting their findings. However, large clinical research efforts in recent decades have identified numerous genetic and environmental risk factors for schizophrenia. The combined data strongly support the neurodevelopmental hypothesis of schizophrenia and underscore the importance of the common converging effects of diverse insults. In this review, we discuss the evidence that genetic and environmental risk factors that predispose to schizophrenia disrupt the development and normal functioning of the GABAergic system.

Indexed as

AnimalsBraingamma-Aminobutyric AcidHumansReceptors, GABARisk FactorsSchizophreniagamma-Aminobutyric AcidReceptors, GABA

Identifiers

PMID24759129
PMCPMC4262918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.